Modern surgery for gastric cancer - Japanese perspective

Scandinavian Journal of Surgery

Volumn 95, Issue 4, 2006, Pages 232-235

  Sasako, Mitsuru ^a   Saka, M ^a   Fukagawa, T ^a   Katai, H ^a   Sano, T ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Function preserving surgery; Gastric cancer; Lymph node dissection; Radical surgery; Surgical treatment; Tailored surgery

Indexed keywords

CANCER MORTALITY; CANCER RADIOTHERAPY; GASTRECTOMY; GOLD STANDARD; HUMAN; MORBIDITY; QUALITATIVE ANALYSIS; REVIEW; STOMACH CANCER; SURGICAL APPROACH; SURGICAL MORTALITY;

EID: 33846141129     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/145749690609500404     Document Type: Review

References (27)

1. Ajani JA, Winter K, Okawara GS, Donohue JH, Pister PWT, Crane CH, Greskovich JF, Anne PR, Bradley JD, Willett C, Rich TA: Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response. J Clin Oncol 2006;24:3953-3958
2. Gotoda T: A large endoscopic resection by endoscopic submucosal dissection procedure for early gastric cancer. Clinical Gastroenterol & Hepatol 2005;3(7 Suppl 1):S71-73
3. Oda I, Gotoda T, Hamanaka H, Eguchi T, Saito Y, Matsuda T, Bhandari P, Emura F, Saito D, Ono H: Endoscopic submucosal dissection for early gastric cancer: technical feasibility, operation time and complications from a large consecutive series. Dig Endosc 2005;17:54-58
4. Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM, Dixon MF, Fenoglio-Preiser CM, Flejou J-F, Geboes K, Hattori T, Hirota T, Itabashi M, Iwafuchi M, Iwashita A, Kim YI, Kirchner T, Klimpfinger M, Koike M, Lauwers GY, Lewin KJ, Oberhuber G, Offiner F, Price AB, Rubio CA, Shimizu M, Shimoda T, Sipponen P, Solcia E, Stolte M, Waranabe H, Yamabe H: The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251-255
5. Binenkamp JJ, Hermans J, Sasako M, van De Velde CJH for the Dutch Gastric Cancer Group. New Engl J Med 1999;340:908-914
6. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P: Patient survival after D1 and D2 resection for gastric cancer: long-term results of the MRC randomized surgical trial. Br J Cancer 1999;79:1522-1530
7. Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Aral K, Yamamura Y, Okajima K: Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy - Japan Clinical Oncology Group Study 9501. J Clin Oncol 2004;22:2767-2773
8. Isozaki H, Okajima K, Fujii K: Effectiveness of paraaortic lymph node dissection for advanced gastric cancer. Hepatogastroenterol 46;1999:549-554
9. Sasako M, Sano T, Yamamoto S, Nashimoto A, Kurita A, Furukawa H, Tsujinaka T, Kinoshita T, Arai K: Randomized phase III trial of standard D2 versus D2 + para-aortic lymph node dissection for clinically MO advanced gastric cancer: JCOG 9501. J Clin Oncol 2006;24:934 s
10. Nakajima T: Gastric Cancer Treatment Guideline in Japan. Gastric Cancer 2002;5:1-5
11. Brennan MF: Lymph-node dissection for gastric cancer. N Engl J Med 1999;340:956-957
12. Sasako M: Principles of surgical treatment for curable gastric cancer. J Clin Oncol 2003;23 s:274s-275s
13. Hulscher JBF, van Sandick JW, de Boer AGEM, Wijnhoven BPL, Tijssen JGP, Fockens P, Stalmeier PFM, ten Kate FJW, van Dekken H, Obertop H, Tilanus HW, van Lanschot JJB: Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347:1662-1669
14. Sasako M: Role of surgery in multidisciplinary treatment for solid cancers. Int J Clin Oncol 2004;9:346-351
15. Degiuli M, Sasako M, Ponti A, Soldati T, Danese F, Calvo F: Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian Gastric Cancer Study Group prospective multicenter surgical study. J Clin Oncol 1998;16:1490-1493
16. Roviello F, Marrelli D, Morgagni P, de Manzoni G, di Leo A, Vindigni C, Saragoni L, Tommezzoli A, Kurihara H: Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study. Ann Surg Oncol 2002;9:894-900
17. Bunt AMG, Hermans J, Boon MC, van de Velde CJH, Sasako M, Fleuren GJ, Bruijn JA: Evaluation of the extent of lymphadenectomy in a randomized trial of Western - versus Japanese-type surgery in gastric cancer. J Clin Oncol 1994;12:417-422
18. Hundahl SA, Macdonald JS, Benedetti J, Fitzsimmons T: Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol 2002;9:278-286
19. Peeters KCMJ, Hundahl SA, Kranenbarg EK, Hartrink H, van de Velde CJH: Low Maruyama index surgery for gastric cancer: blinded reanalysis of the Dutch D1-D2 trial. World J Surg 2005;29:1576-1584
20. Sasako M: Risk factors for surgical treatment in the Dutch gastric cancer trial. Br J Surg 1997;84:1567-1571
21. Wu CW, Hsiung CA, Lo SS, Hsieh MC, Chen JH, Li AFY, Lui WY, Peng JW: Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 2006;309-315
22. Macdonald JS, Smalley SR, Benedetti J, Este SANC, Stemmermann GN, Haller DG, Ajani JA, Gunderson LL, Jessup JM, Martenson JA: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725-730
23. Macdonald JS: Postoperative combined radiation and chemotherapy improves disease-free survival (DPS) and overall survival (OS) in resected adenocarcinoma of the stomach and gastroesophageal junction: Update of the results of Intergroup tudy INT-0116 (SWOG 9008) (Virtual meeting of ASCO GI Symposium) Proc Am Soc Clin Oncol 19:1a, 2000
24. Cunningham D, Allum WH, Stenning SP, Thompson JN, van de Velde CJH, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Cua YJ: Peri-operative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11-20
25. Ohtsu A, Sasako M: Overview of adjuvant therapy for resected gastric cancer: differences in Japan and the United States. Semin Oncol 2005;32:ss101-104
26. Katai H, Sano T, Sasako M, Fukagawa T, Saka M: Update on surgery of gastric cancer: new procedures versus standard technique. Dig Surg 2004;22:338-344
27. Sasako M, Sano T, Yamamoto S, Sairenji M, Arai K, Kinoshita T, Nashimoto A, Hiratsuka M: Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol 2006;7:644-651